{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:59:10Z","timestamp":1794513550752,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["82373826"],"award-info":[{"award-number":["82373826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04167-x","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:54:10Z","timestamp":1772092450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PD1 cell membrane-coated Ru(ll)-Pt(lV) complex nanoparticles inhibit liver metastatic melanoma via cascade immune activation"],"prefix":"10.1186","volume":"24","author":[{"given":"Cong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy Thu","family":"Phann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feijun","family":"OuYang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duanzhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-Yun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"4167_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA. Cutaneous melanoma. Lanc. 2023;402:485\u2013502.","journal-title":"Lanc."},{"key":"4167_CR2","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.jid.2023.02.030","volume":"143","author":"GS Leichner","year":"2023","unstructured":"Leichner GS, Schweitzer I, Dror S, Levin L, Geva P, Golan T, et al. Primary melanoma miRNA trafficking induces lymphangiogenesis. J Invest Dermatol. 2023;143:1788-1798.e1787.","journal-title":"J Invest Dermatol"},{"key":"4167_CR3","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s43018-021-00272-y","volume":"2","author":"S Garc\u00eda-Silva","year":"2021","unstructured":"Garc\u00eda-Silva S, Benito-Mart\u00edn A, Nogu\u00e9s L, Hern\u00e1ndez-Barranco A, Mazariegos MS, Santos V, et al. Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism. Nat Cancer. 2021;2:1387\u2013405.","journal-title":"Nat Cancer"},{"key":"4167_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01906-1","volume":"22","author":"S Babaei","year":"2024","unstructured":"Babaei S, Fadaee M, Abbasi-Kenarsari H, Shanehbandi D, Kazemi T. Exosome-based immunotherapy as an innovative therapeutic approach in melanoma. Cell Commun Signal. 2024;22:527.","journal-title":"Cell Commun Signal"},{"key":"4167_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0140-6736(25)00553-7","volume":"406","author":"O Pail","year":"2025","unstructured":"Pail O, Lin MJ, Anagnostou T, Brown BD, Brody JD. Cancer vaccines and the future of immunotherapy. Lanc. 2025;406:189\u2013202.","journal-title":"Lanc"},{"key":"4167_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001481","author":"S Kim","year":"2021","unstructured":"Kim S, Kim SA, Nam GH, Hong Y, Kim GB, Choi Y, et al. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis. J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2020-001481.","journal-title":"J Immunother Cancer"},{"key":"4167_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70346","volume":"6","author":"X Wang","year":"2025","unstructured":"Wang X, Jing J. Cancer immunotherapy in combination with radiotherapy and\/or chemotherapy: mechanisms and clinical therapy. MedComm. 2025;6:e70346.","journal-title":"MedComm"},{"key":"4167_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007625","author":"J Li","year":"2023","unstructured":"Li J, Han X, Sun M, Li W, Yang G, Chen H, et al. Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2023-007625.","journal-title":"J Immunother Cancer"},{"key":"4167_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.45596","volume":"5","author":"AS Watson","year":"2022","unstructured":"Watson AS, Goutam S, Stukalin I, Ewanchuk BW, Sander M, Meyers DE, et al. Association of immune-related adverse events, hospitalization, and therapy resumption with survival among patients with metastatic melanoma receiving single-agent or combination immunotherapy. JAMA Netw Op. 2022;5:e2245596.","journal-title":"JAMA Netw Op"},{"key":"4167_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121433","volume":"282","author":"S Zhang","year":"2022","unstructured":"Zhang S, Wang J, Kong Z, Sun X, He Z, Sun B, et al. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy. Biomater. 2022;282:121433.","journal-title":"Biomater"},{"key":"4167_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122257","volume":"301","author":"M Wang","year":"2023","unstructured":"Wang M, He M, Zhang M, Xue S, Xu T, Zhao Y, et al. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy. Biomater. 2023;301:122257.","journal-title":"Biomater"},{"key":"4167_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121425","volume":"282","author":"R Guo","year":"2022","unstructured":"Guo R, Wang S, Zhao L, Zong Q, Li T, Ling G, et al. Engineered nanomaterials for synergistic photo-immunotherapy. Biomater. 2022;282:121425.","journal-title":"Biomater"},{"key":"4167_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.46094","volume":"6","author":"EX Chen","year":"2023","unstructured":"Chen EX, Loree JM, Titmuss E, Jonker DJ, Kennecke HF, Berry S, et al. Liver metastases and immune checkpoint inhibitor efficacy in patients with refractory metastatic colorectal cancer: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2023;6:e2346094.","journal-title":"JAMA Netw Open"},{"key":"4167_CR14","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino MS, Larkin J, Long GV. Immune checkpoint inhibitors in melanoma. Lanc. 2021;398:1002\u201314.","journal-title":"Lanc"},{"key":"4167_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu J, Green MD, Li S, Sun Y, Journey SN, Choi JE, et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med. 2021;27:152\u201364.","journal-title":"Nat Med"},{"key":"4167_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40727-7","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Fang W, Zhou S, Zhu D, Chen R, Gao X, et al. Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. Nat Commun. 2023;14:5123.","journal-title":"Nat Commun"},{"key":"4167_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58369-2","volume":"16","author":"M Notaro","year":"2025","unstructured":"Notaro M, Borghetti M, Bresesti C, Giacca G, Kerzel T, Mercado CM, et al. In vivo armed macrophages curb liver metastasis through tumor-reactive T-cell rejuvenation. Nat Commun. 2025;16:3471.","journal-title":"Nat Commun"},{"key":"4167_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.21037\/atm.2017.06.47","volume":"5","author":"N Karachaliou","year":"2017","unstructured":"Karachaliou N, Gonzalez-Cao M, Sosa A, Berenguer J, Bracht JWP, Ito M, et al. The combination of checkpoint immunotherapy and targeted therapy in cancer. Ann Transl Med. 2017;5:388.","journal-title":"Ann Transl Med"},{"key":"4167_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3604","author":"SP Arlauckas","year":"2017","unstructured":"Arlauckas SP, Garris CS, Kohler RH, Kitaoka M, Cuccarese MF, Yang KS, et al. In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aal3604.","journal-title":"Sci Transl Med"},{"key":"4167_CR20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41591-024-03411-x","volume":"31","author":"R Dummer","year":"2025","unstructured":"Dummer R, Robert C, Scolyer RA, Taube JM, Tetzlaff MT, Menzies AM, et al. Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1\/2 trial. Nat Med. 2025;31:144\u201351.","journal-title":"Nat Med"},{"key":"4167_CR21","first-page":"237","volume":"34","author":"L Garc\u00eda-Hevia","year":"2024","unstructured":"Garc\u00eda-Hevia L, Soltani R, Gonz\u00e1lez J, Chaloin O, M\u00e9nard-Moyon C, Bianco A. M LF: Carbon nanotubes targeted to the tumor microenvironment inhibit metastasis in a preclinical model of melanoma. Bioact Mater. 2024;34:237\u201347.","journal-title":"Bioact Mater"},{"key":"4167_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09709-1","author":"M Palma","year":"2025","unstructured":"Palma M, Chaufan M, Breuer CB, M\u00fcller S, Sabatier M, Fraser CS, et al. Lymph node environment drives FSP1 targetability in metastasizing melanoma. Nat. 2025. https:\/\/doi.org\/10.1038\/s41586-025-09709-1.","journal-title":"Nat"},{"key":"4167_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jconrel.2022.05.024","volume":"347","author":"YQ Wang","year":"2022","unstructured":"Wang YQ, Huang C, Ye PJ, Long JR, Xu CH, Liu Y, et al. Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivo. J Control Rel. 2022;347:400\u201313.","journal-title":"J Control Rel"},{"key":"4167_CR24","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1039\/C4CS00508B","volume":"44","author":"Y Shan","year":"2015","unstructured":"Shan Y, Wang H. The structure and function of cell membranes examined by atomic force microscopy and single-molecule force spectroscopy. Chem Soc Rev. 2015;44:3617\u201338.","journal-title":"Chem Soc Rev"},{"key":"4167_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5049\/EBP.2014.12.2.55","volume":"12","author":"GS Oh","year":"2014","unstructured":"Oh GS, Kim HJ, Shen A, Lee SB, Khadka D, Pandit A, et al. Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrolyte Blood Press. 2014;12:55\u201365.","journal-title":"Electrolyte Blood Press"},{"key":"4167_CR26","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","volume":"54","author":"DY Oh","year":"2021","unstructured":"Oh DY, Fong L. Cytotoxic CD4(+) T cells in cancer: expanding the immune effector toolbox. Immun. 2021;54:2701\u201311.","journal-title":"Immun"},{"key":"4167_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01234-1","volume":"19","author":"C Li","year":"2020","unstructured":"Li C, Jiang P, Wei S, Xu X, Wang J. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol Cancer. 2020;19:116.","journal-title":"Mol Cancer"},{"key":"4167_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","volume":"23","author":"L Cassetta","year":"2023","unstructured":"Cassetta L, Pollard JW. A timeline of tumour-associated macrophage biology. Nat Rev Cancer. 2023;23:238\u201357.","journal-title":"Nat Rev Cancer"},{"key":"4167_CR29","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","volume":"40","author":"Q Shi","year":"2022","unstructured":"Shi Q, Shen Q, Liu Y, Shi Y, Huang W, Wang X, et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell. 2022;40:1207-1222.e1210.","journal-title":"Cancer Cell"},{"key":"4167_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN. Cancer Cell. 2009;16:183\u201394.","journal-title":"Cancer Cell"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04167-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:00:45Z","timestamp":1774972845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04167-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4167"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04167-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}